Valuation: Stem Cells Spin S.A.

Market Cap 19.84M 5.03M 4.49M 4.12M 3.75M 7.03M 476M 7.17M 49.22M 251M 18.88M 18.48M 794M P/E 2024
-15.6x
P/E 2025 -31.9x
Enterprise Value 19.93M 5.05M 4.51M 4.14M 3.76M 7.06M 478M 7.2M 49.43M 252M 18.96M 18.56M 797M EV / Sales 2024
151x
EV / Sales 2025 257x
Free-Float
57.28%
Yield 2024 *
-
Yield 2025 -
1 day+2.13%
1 week+9.09%
1 month+2.13%
3 months-2.04%
6 months+20.00%
Current year+18.23%
1 week 0.47
Extreme 0.47
0.48
1 month 0.44
Extreme 0.44
0.49
Current year 0.33
Extreme 0.33
0.54
1 year 0.28
Extreme 0.28
0.54
3 years 0.14
Extreme 0.14
0.82
5 years 0.14
Extreme 0.14
1.12
10 years 0.14
Extreme 0.14
2.04
Manager TitleAgeSince
Chief Executive Officer 45 2016-12-31
Director TitleAgeSince
Director/Board Member 74 2022-06-27
Director/Board Member 64 -
Director/Board Member - 2022-03-14
Change 5-day change 1-year change 3-year change Capi.($)
+2.13%+9.09%+21.21%+33.33% 5.03M
-2.37%-4.19%+39.49%+63.21% 63.77B
-2.87%+0.49%+10.45%+69.18% 56.37B
+0.62%+2.11%+20.22%+102.56% 54.62B
-3.33%-5.54%+20.83%+35.69% 44.06B
-2.45%-2.59%+15.84%+98.45% 42.11B
-1.64%+2.32%+217.16%+789.69% 41B
-5.47%+24.76%+98.34%+87.34% 34.92B
+0.21%-1.23%+14.81%+47.35% 32.82B
-2.90%+17.12%-41.30%+337.07% 24.7B
Average -1.71%+7.86%+41.70%+166.39% 39.43B
Weighted average by Cap. -2.06%+5.64%+44.63%+163.71%

Financials

2024 2025
Net sales 54.28K 13.76K 12.29K 11.27K 10.26K 19.23K 1.3M 19.61K 135K 688K 51.65K 50.55K 2.17M 65.74K 16.67K 14.88K 13.65K 12.42K 23.29K 1.58M 23.75K 163K 833K 62.55K 61.21K 2.63M
Net income -520K -132K -118K -108K -98.3K -184K -12.49M -188K -1.29M -6.59M -495K -484K -20.82M -526K -133K -119K -109K -99.31K -186K -12.62M -190K -1.3M -6.66M -500K -489K -21.03M
Net Debt 69.28K 17.56K 15.68K 14.39K 13.09K 24.54K 1.66M 25.03K 172K 878K 65.92K 64.52K 2.77M 84.58K 21.44K 19.15K 17.57K 15.98K 29.96K 2.03M 30.56K 210K 1.07M 80.48K 78.77K 3.38M
Projected Income Statement - Annual - Stem Cells Spin S.A.
Logo Stem Cells Spin S.A.
Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.
Employees
1
Date Price Change Volume
26-10-28 PLN 0.4800 +2.13% 670
26-10-27 PLN 0.4700 -.--% 20